Ondane Injection
Composition :
Each ml ONDANE® contain Ondansetron HCl equivalent with Ondansetron 2 mg
Pharmacology :
Ondansetron a 5 – HT3 receptor antagonist that works selectively and competitively in preventing and overcoming nausea and vomiting due to treatment with sitostatica and radiotherapy.
Indication :
Treatment nausea and vomiting due to chemotherapy and radiotherapy and surgery.
Dosage :
Treatment postoperative nausea and vomiting:
- 4 mg/i.m. as single dose or injection i.v. by slowly.
Pencegahan mual dan muntah karena kemoterapi :
* Afult:
– Very emetogenic chemotherapy, example cisplatin. The forst injection Ondansetron 8 mg secara i.v. by slowly or infused for 15 minutes before given chemotherapy, followed with infuse 1 mg Ondansetron/hour for continuous for less than 24 hours or 2 injection 8 mg i.v. slowly or infused for 15 minutes at an interval of 4 hours. Or it could be followed by giving 8 mg orally twice daily for less than 5 days.
– Less emetogenic chemotherapy, exaple cyclospamide. Injection i.v. 8 mg Ondansetron by slowly or infused for 15 minutes immediately before chemotherapy, followed by 8 mg orally twice daily for less than 5 days.
* Children > 4 years old :
5 mg/ml by i.v. for 15 minutes before given chemotherapy, followed by giving 4 mg orally every 12 hours for less than 5 days.
- Elderly :
Ondansetron can be well tolerated in patients over 65 without changing the dosage, frequency or mode of administration.
- Patients with impaired renal function:
Does not require daily dose adjustment, frequency or administration.
- Patients with impaired liver function:
Total daily dose should not exceed 8 mg.
Presentation and Registration Number :
ONDANE® 4 Injection Box 5 ampoules @ 2 ml; DKL1008015743A1
ONDANE® 8 Injection Box 5 ampoules @ 4 ml; DKL1008015743A1
ON MEDICAL PRESCRIPTION ONLY
Categorised in:
This post was written by admin